Growth Metrics

Eton Pharmaceuticals (ETON) Receivables - Net (2019 - 2025)

Eton Pharmaceuticals' Receivables - Net history spans 7 years, with the latest figure at $11.8 million for Q4 2025.

  • On a quarterly basis, Receivables - Net rose 119.31% to $11.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $11.8 million, a 119.31% increase, with the full-year FY2025 number at $11.8 million, up 119.31% from a year prior.
  • Receivables - Net hit $11.8 million in Q4 2025 for Eton Pharmaceuticals, up from $5.0 million in the prior quarter.
  • Over the last five years, Receivables - Net for ETON hit a ceiling of $11.8 million in Q4 2025 and a floor of $300000.0 in Q1 2021.
  • Historically, Receivables - Net has averaged $3.5 million across 5 years, with a median of $3.5 million in 2023.
  • Biggest five-year swings in Receivables - Net: skyrocketed 10316.67% in 2021 and later plummeted 62.96% in 2022.
  • Tracing ETON's Receivables - Net over 5 years: stood at $5.0 million in 2021, then tumbled by 62.96% to $1.9 million in 2022, then soared by 84.18% to $3.4 million in 2023, then surged by 57.17% to $5.4 million in 2024, then skyrocketed by 119.31% to $11.8 million in 2025.
  • Business Quant data shows Receivables - Net for ETON at $11.8 million in Q4 2025, $5.0 million in Q3 2025, and $5.0 million in Q2 2025.